4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MapLight Therapeutics, Inc. (MPLT) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 133 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, MPLT reported $0M in revenue and ($161M) in net income.
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $0M | — | — |
| Operating Income (EBIT) | ($169M) | — | — |
| Net Income | ($161M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | — | $0M |
| Operating Income (EBIT) | ($64M) | ($83M) | ($32M) | ($24M) | ($23M) |
| Net Income | ($61M) | ($80M) | ($29M) | ($22M) | ($21M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $480M | — | — | — |
| Total Liabilities | $21M | $22M | $20M | $18M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MPLT viewer.
About TickerBase · Data methodology & sources